Blue Earth Diagnostics is a molecular imaging diagnostics company focused on the development and commercialization of novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by recognized experts in the clinical development and commercialization of innovative nuclear medicine products.
Mission Statement “Developing molecular imaging agents for cancer.”
This profile was automatically created. Find out more about Blue Earth Diagnostics on their company website or check out their opportunities in the opportunities section of this page.